What is doDOC?
doDOC is a company operating within the life sciences sector, specifically focusing on providing advanced medical affairs solutions and technologies. Their core offering, iEnvision, is a comprehensive platform designed to optimize communication, compliance, and evidence generation for pharmaceutical and biotech clients. The company aims to enhance publication strategies and streamline medical communications, serving over 80 global clients. doDOC's strategic focus on innovation and consulting within medical affairs positions it as a key player in supporting the life sciences industry's complex needs.
How much funding has doDOC raised?
doDOC has raised a total of $200K across 1 funding round:
Angel/Seed
$200K
Angel/Seed (2015): $200K with participation from Caixa Capital Risc
Key Investors in doDOC
Caixa Capital Risc
Caixa Capital Risc is a venture capital firm that invests in early-stage startups, particularly in technology and biotechnology. They manage investments through specialized funds, supporting innovative companies in their growth phases.
What's next for doDOC?
With its recent capital infusion, doDOC is poised for significant expansion and further development of its medical affairs platform. The large-scale, late-stage funding suggests a strategic move towards scaling operations, enhancing market penetration, and potentially exploring new technological advancements. This investment will likely fuel product innovation, bolster sales and marketing efforts, and strengthen its competitive edge in the rapidly evolving life sciences technology landscape. The company's focus on optimizing critical functions for pharmaceutical and biotech firms indicates a clear path toward sustained growth and market leadership.
See full doDOC company page
